Cosmetic Skin Lightening : Contextualizing Biomedical and Ethical Issues
Copyright © 2024. Published by Elsevier Inc..
The skin lightening (SL) industry has a global reach and is projected to continue to grow over the coming decade. While SL treatments may be safely prescribed for treatment of some dermatologic conditions, many over-the-counter SL products contain ingredients that can cause harm to the skin and other organ systems. Given a lack of transparent information to patients and the historical colorist foundation that contextualizes a component of the cosmetic SL industry, dermatologists need to navigate biomedical and ethical concerns when explaining SL products to patients. This commentary briefly outlines the medical ethical issues surrounding this topic and describes avenues by which dermatologists may provide informed patient care that best supports beneficence, justice, autonomy, and nonmaleficence.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - year:2024 |
|---|---|
| Enthalten in: |
Clinics in dermatology - (2024) vom: 12. Apr. |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Parente, James Bradley M [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Ethics |
|---|
| Anmerkungen: |
Date Revised 14.04.2024 published: Print-Electronic Citation Status Publisher |
|---|
| doi: |
10.1016/j.clindermatol.2024.04.001 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM371052998 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM371052998 | ||
| 003 | DE-627 | ||
| 005 | 20240415234436.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240415s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.clindermatol.2024.04.001 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1376.xml |
| 035 | |a (DE-627)NLM371052998 | ||
| 035 | |a (NLM)38615979 | ||
| 035 | |a (PII)S0738-081X(24)00058-0 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Parente, James Bradley M |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Cosmetic Skin Lightening |b Contextualizing Biomedical and Ethical Issues |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 14.04.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status Publisher | ||
| 520 | |a Copyright © 2024. Published by Elsevier Inc. | ||
| 520 | |a The skin lightening (SL) industry has a global reach and is projected to continue to grow over the coming decade. While SL treatments may be safely prescribed for treatment of some dermatologic conditions, many over-the-counter SL products contain ingredients that can cause harm to the skin and other organ systems. Given a lack of transparent information to patients and the historical colorist foundation that contextualizes a component of the cosmetic SL industry, dermatologists need to navigate biomedical and ethical concerns when explaining SL products to patients. This commentary briefly outlines the medical ethical issues surrounding this topic and describes avenues by which dermatologists may provide informed patient care that best supports beneficence, justice, autonomy, and nonmaleficence | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Ethics | |
| 650 | 4 | |a Health Disparities | |
| 650 | 4 | |a Pigmentation | |
| 650 | 4 | |a Racial identify | |
| 650 | 4 | |a Shared decision making | |
| 650 | 4 | |a Skin Lightening, Colorism, Equity, Justice | |
| 700 | 1 | |a Silva, Genevieve S |e verfasserin |4 aut | |
| 700 | 1 | |a Gotschall, Jeromy W |e verfasserin |4 aut | |
| 700 | 1 | |a Ferreira, Alana L |e verfasserin |4 aut | |
| 700 | 1 | |a Grant-Kels, Jane M |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Clinics in dermatology |d 1987 |g (2024) vom: 12. Apr. |w (DE-627)NLM012632732 |x 1879-1131 |7 nnns |
| 773 | 1 | 8 | |g year:2024 |g day:12 |g month:04 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.clindermatol.2024.04.001 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |j 2024 |b 12 |c 04 | ||